| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO | See Remarks
1 company
Mills Kenneth T. is a Director at REGENXBIO Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $5.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2025 | RGNX Regenxbio Inc. | Director | Sale+OE | 20,602 | $7.91 | $163,046.29 | -4.2% | -6.4% | - | |
| Jul 25, 2024 | RGNX Regenxbio Inc. | Director | Sale+OE | 27,590 | $13.88 | $382,934.01 | -3.3% | -32.3% | -37.7% | |
| Jul 17, 2024 | RGNX Regenxbio Inc. | Director | Sale+OE | 2,410 | $13.77 | $33,191.88 | -0.3% | -22.4% | -34.6% | |
| May 14, 2024 | RGNX Regenxbio Inc. | President And CEO | Sale+OE | 15,000 | $15.81 | $237,222.00 | -3.5% | -24.4% | -47.3% | |
| Apr 15, 2024 | RGNX Regenxbio Inc. | President And CEO | Sale+OE | 15,000 | $18.19 | $272,871.00 | -3.5% | -28.6% | -63.7% | |
| Mar 14, 2024 | RGNX Regenxbio Inc. | President And CEO | Sale+OE | 15,000 | $21.86 | $327,942.00 | -3.5% | -39.8% | -69.2% | |
| Feb 14, 2024 | RGNX Regenxbio Inc. | President And CEO | Sale+OE | 15,000 | $16.76 | $251,348.76 | -1.8% | -5.9% | -56.4% | |
| Jan 16, 2024 | RGNX Regenxbio Inc. | President And CEO | Sale+OE | 45,000 | $15.18 | $682,992.00 | -9.9% | +18.0% | -51.3% | |
| Dec 19, 2023 | RGNX Regenxbio Inc. | President And CEO | Sale+OE | 45,000 | $19.69 | $885,825.00 | -11.2% | +13.9% | -60.4% | |
| Nov 8, 2021 | RGNX Regenxbio Inc. | President And CEO | Sale+OE | 1,500 | $40.00 | $60,000.00 | -0.5% | -30.2% | -45.8% |